EMBL
MARTINI

Home

FAQs

Examples

About


Keyword Enhancement Results (metastatic vs primary melanoma)

Significant Terms = 264 , Total Terms = 75631 , Input Data , Raw Output Data
12 MAGE 5'-phosphates 941 pseudogenes ANAPHASE ANEUPLOIDY APC/ C ARREST ASSEMBLED ASSEMBLIES Ataxia Telangiectasia ATM kinases ATPase autism BINARIES BIOGENESIS BONE MARROW CELL BRONCHIAL BUBR1 CALCIUM-DEPENDENT calcium Camptothecin CDC20 CDH1 cdk2 kinase Cdk2/ CDT1 CELL CYCLE CELL DIVISION CENTROSOME CEREVISIAE CHAPERONE CHECKPOINT Chk1 protein kinase CHROMATID CLADE Claspin CLASSIFICATION CO-IMMUNOPRECIPITATION COHESIN CONNECTION COORDINATION CORNEA CORNIFIED CROSS-VALIDATION cyclin B cyclin-dependent kinases CYCLIN-DEPENDENT CYCLOSOME cystic fibrosis gene CYTOGENETIC CYTOKINESIS DAUGHTER DEGRADATION DEPLETION DESMOSOME DISPENSABLE DNA DAMAGE DNA REPAIR DNA REPLICATION DNA-binding protein DOUBLE-STRAND BREAK DOUBLE-STRANDED DNA DYNAMICS E2F transcription factor E2F4 EGF ELONGATION FACTOR ELONGATION EMPIRICAL END EPIDERMAL CELL EPITHELIAL CELL EPITHELIAL EPITHELIUM ESSENTIAL EUKARYOTE EUKARYOTIC CELL EUKARYOTIC FALSE-POSITIVE FORK FRACTION G2 PHASE GLOBAL guanine nucleotide exchange factors guanine nucleotide H2B HAIR FOLLICLE HEALTH HEAT-SHOCK HeLa cell nuclear phosphoproteins HELA CELL helicase, lymphoid-specific high-sensitive reverse transcription-nested polymerase chain HISTONE histones HIT HSPs human gene MAGE-1 human protein-protein IMMUNODEPLETED IMPRINTING IN-GEL INDEPENDENT INITIATION FACTOR INTEGRATED INTERMEDIATE FILAMENT INTERPHASE INVALUABLE Involucrin JUNCTIONAL KERATINOCYTE kinase kinases KINETICS KINETOCHORE LATES LAYER LEAVES LIGASES LIGATED LININGS LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY LYSATE M PHASE MACHINE MAD1 MAD2 MAGE-A antigens MAGE-A MAGE MAPPINGS MASS SPECTROMETRIES MATCHED MECHANISM melanoma antigen gene METAPHASE MICROINJECTION MICROTUBULE MIDBODIES MIDZONE MINICHROMOSOME MISALIGNMENT MISSEGREGATION MITOTIC SPINDLE MITOTIC MONOPOLAR MOTIF MOTOR MULTIPOLAR MULTISUBUNIT Mus sp NASCENT NATIONALS NETWORK NEURITE Nicotiana tabacum NONPHOSPHORYLATABLE NONREDUNDANT novel protein-protein NUCLEAR ANTIGEN NUCLEAR PORE nuclear protein NUCLEOLAR NUCLEUS Oligoribonucleotide oligoribonucleotides over 100 disease-associated proteins PAIRWISE PCNA PERCENT PERMIT phosphopeptides PHOSPHOPROTEIN PHOSPHORYLATION pol polo-like kinase 1 polypeptide chain elongation factor 1 alpha POLYPLOID POSTTRANSLATIONAL pre-rRNA PROMETAPHASE PROPHASE PROTEASOME protein complex protein kinase PROTEOME PSMS Psoriasis PSORIATICS PURIFIED PYROPHOSPHATASE QUIESCENT RAD17 RDNA REBINDING REGULATORY REMAIN REMOVED REPAIR Replication protein A REPLICATION REVERSIBLE ribonucleotide ribosomal gene RIBOSOME RING-SHAPED RNA polymerase I subunit RNA POLYMERASE RP-A S PHASE Saccharomyces cerevisiae SCALE Schizosaccharomyces pombe SCHIZOSACCHAROMYCES SEGREGATION single MAGE-A antigen SITE-SPECIFIC Skin Diseases SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLE small nuclear ribonucleoprotein specific kinase-substrate SPECTRAL spindle associated proteins SQUAMOUS EPITHELIUM SSDNA STABLE ISOTOPE STARVATION Starvation STEM-LOOP STEP STIMULI STRATIFIED EPITHELIA STRATIFIED STRATUM CORNEUM STRINGENT SUBCELLULAR SUBCOMPLEX SUBSTRATE SUBUNIT SUPERFAMILIES SUPPLEMENTAL SUPRABASAL SURFACE SURPRISINGLY SYNTHESIS SYSTEMATICS TELOPHASE TEMPORAL TOBACCO topoisomerase I TOPOISOMERASE TOPOLOGIES TRANSMISSION ubiquitin ligases UBIQUITIN UBIQUITINS UNALIGNED UNATTACHED UNLIKE UNPRECEDENTED UNSOLVED UPPER VIRAL PROTEIN Xeroderma Pigmentosum

Term Type Set A
(282 Genes)
Set B
(876 Genes)
Enhancement Factor Adjusted P Value
HELA CELL Bioterm 117 (41%) 155 (17%) 2.345 5.105E-13
ANAPHASE Bioterm 27 (9%) 4 (0%) 20.968 1.271E-11
LIGASES Bioterm 111 (39%) 152 (17%) 2.268 2.518E-11
CYTOKINESIS Bioterm 35 (12%) 14 (1%) 7.766 1.511E-10
MITOTIC SPINDLE Bioterm 37 (13%) 17 (1%) 6.761 2.507E-10
CHROMATID Bioterm 31 (10%) 10 (1%) 9.63 2.678E-10
NASCENT Bioterm 39 (13%) 20 (2%) 6.057 3.509E-10
EUKARYOTIC Bioterm 93 (32%) 121 (13%) 2.388 8.279E-10
UBIQUITIN Bioaction 85 (30%) 106 (12%) 2.491 2.222E-09
PHOSPHOPROTEIN Bioterm 59 (20%) 56 (6%) 3.273 5.875E-09
KERATINOCYTE Bioterm 19 (6%) 201 (22%) 3.406 9.881E-09
UBIQUITINS Bioterm 76 (26%) 92 (10%) 2.566 1.155E-08
MISSEGREGATION Bioaction 25 (8%) 7 (0%) 11.094 1.260E-08
KINASE Gene 73 (25%) 87 (9%) 2.607 1.829E-08
CHECKPOINT Bioterm 36 (12%) 21 (2%) 5.325 1.934E-08
CEREVISIAE Bioterm 49 (17%) 42 (4%) 3.624 3.514E-08
POSTTRANSLATIONAL Bioterm 64 (22%) 70 (7%) 2.84 3.530E-08
RNA POLYMERASE Bioterm 24 (8%) 7 (0%) 10.65 4.316E-08
SKIN DISEASES Disease 1 (0%) 87 (9%) 28.007 4.549E-08
UBIQUITIN LIGASES Gene 49 (17%) 43 (4%) 3.54 4.997E-08
NUCLEOLAR Bioterm 34 (12%) 20 (2%) 5.281 7.479E-08
GUANINE NUCLEOTIDE EXCHANGE FACTORS Gene 48 (17%) 43 (4%) 3.468 1.142E-07
HUMAN PROTEIN-PROTEIN Gene 105 (37%) 166 (18%) 1.965 1.479E-07
EUKARYOTE Bioterm 43 (15%) 35 (3%) 3.816 1.583E-07
INTERPHASE Bioterm 39 (13%) 29 (3%) 4.178 1.951E-07
DYNAMICS Bioterm 137 (48%) 252 (28%) 1.689 2.230E-07
PROTEIN KINASE Gene 76 (26%) 101 (11%) 2.337 3.536E-07
M PHASE Bioterm 31 (10%) 18 (2%) 5.35 3.885E-07
MASS SPECTROMETRIES Bioterm 102 (36%) 167 (19%) 1.897 1.105E-06
CORNEA Bioaction 6 (2%) 112 (12%) 6.009 1.248E-06
RNA POLYMERASE I SUBUNIT Gene 17 (6%) 3 (0%) 17.603 1.461E-06
RIBOSOMAL GENE Gene 17 (6%) 3 (0%) 17.603 1.461E-06
EPITHELIAL Bioterm 41 (14%) 273 (31%) 2.144 1.575E-06
FALSE-POSITIVE Bioterm 53 (18%) 58 (6%) 2.839 1.922E-06
EPITHELIUM Bioaction 44 (15%) 284 (32%) 2.078 2.367E-06
HELICASE, LYMPHOID-SPECIFIC Gene 14 (4%) 1 (0%) 43.489 2.476E-06
TEMPORAL Bioterm 82 (29%) 123 (14%) 2.071 3.489E-06
DAUGHTER Bioterm 30 (10%) 20 (2%) 4.66 4.295E-06
CELL CYCLE Bioterm 93 (32%) 152 (17%) 1.901 6.910E-06
S PHASE Bioterm 38 (13%) 33 (3%) 3.577 7.772E-06
PHOSPHORYLATION Bioaction 147 (52%) 297 (33%) 1.538 7.842E-06
GLOBAL Bioterm 124 (43%) 232 (26%) 1.66 7.907E-06
DNA DAMAGE Bioterm 38 (13%) 34 (3%) 3.472 9.933E-06
STRATIFIED Bioaction 9 (3%) 120 (13%) 4.292 1.064E-05
INVALUABLE Bioterm 47 (16%) 52 (5%) 2.808 1.530E-05
SPINDLE ASSOCIATED PROTEINS Gene 19 (6%) 7 (0%) 8.432 1.682E-05
PAIRWISE Bioterm 84 (29%) 134 (15%) 1.947 1.974E-05
OVER 100 DISEASE-ASSOCIATED PROTEINS Gene 80 (28%) 124 (14%) 2.004 2.283E-05
CHAPERONE Bioterm 36 (12%) 32 (3%) 3.495 2.329E-05
ELONGATION Bioaction 86 (30%) 140 (15%) 1.908 2.840E-05
MITOTIC Bioterm 73 (25%) 110 (12%) 2.062 3.287E-05
CELL DIVISION Bioterm 49 (17%) 58 (6%) 2.624 3.931E-05
EPITHELIAL CELL Bioterm 49 (17%) 287 (32%) 1.886 3.967E-05
RIBOSOME Bioterm 31 (10%) 25 (2%) 3.852 4.446E-05
SUBCOMPLEX Bioterm 13 (4%) 2 (0%) 20.191 5.773E-05
LATES Bioterm 73 (25%) 112 (12%) 2.025 5.964E-05
REVERSIBLE Bioterm 73 (25%) 112 (12%) 2.025 5.964E-05
SCHIZOSACCHAROMYCES POMBE Organism 17 (6%) 6 (0%) 8.801 6.155E-05
DNA REPAIR Bioterm 31 (10%) 26 (2%) 3.704 6.552E-05
RING-SHAPED Bioterm 10 (3%) 0 (0%) - 6.819E-05
SSDNA Bioterm 10 (3%) 0 (0%) - 6.819E-05
DOUBLE-STRAND BREAK Bioterm 16 (5%) 5 (0%) 9.94 6.830E-05
PROPHASE Bioterm 14 (4%) 3 (0%) 14.496 6.856E-05
UNSOLVED Bioterm 27 (9%) 20 (2%) 4.194 7.629E-05
CENTROSOME Bioterm 25 (8%) 17 (1%) 4.568 8.045E-05
SQUAMOUS EPITHELIUM Bioterm 1 (0%) 61 (6%) 19.637 8.840E-05
STRATIFIED EPITHELIA Bioterm 0 (0%) 54 (6%) - 9.622E-05
SPECIFIC KINASE-SUBSTRATE Gene 26 (9%) 19 (2%) 4.251 1.071E-04
HELA CELL NUCLEAR PHOSPHOPROTEINS Gene 26 (9%) 19 (2%) 4.251 1.071E-04
MICROINJECTION Bioaction 27 (9%) 21 (2%) 3.994 1.361E-04
SITE-SPECIFIC Bioterm 69 (24%) 106 (12%) 2.022 1.460E-04
BINARIES Bioterm 83 (29%) 139 (15%) 1.855 1.462E-04
SEGREGATION Bioaction 62 (21%) 90 (10%) 2.14 1.484E-04
MIDZONE Bioterm 11 (3%) 1 (0%) 34.17 1.519E-04
PROMETAPHASE Bioterm 11 (3%) 1 (0%) 34.17 1.519E-04
DESMOSOME Bioterm 0 (0%) 52 (5%) - 1.602E-04
GUANINE NUCLEOTIDE Chemical 54 (19%) 73 (8%) 2.298 1.806E-04
LAYER Bioterm 23 (8%) 174 (19%) 2.435 1.876E-04
ESSENTIAL Bioterm 167 (59%) 376 (42%) 1.38 2.176E-04
HIT Bioaction 32 (11%) 30 (3%) 3.313 2.198E-04
CYCLIN-DEPENDENT Bioterm 32 (11%) 30 (3%) 3.313 2.198E-04
STRINGENT Bioterm 92 (32%) 164 (18%) 1.743 2.328E-04
SACCHAROMYCES CEREVISIAE Organism 176 (62%) 405 (46%) 1.35 2.338E-04
G2 PHASE Bioterm 13 (4%) 3 (0%) 13.461 2.408E-04
SMALL NUCLEAR RIBONUCLEOPROTEIN Gene 13 (4%) 3 (0%) 13.461 2.408E-04
TELOPHASE Bioterm 13 (4%) 3 (0%) 13.461 2.408E-04
MIDBODIES Bioterm 14 (4%) 4 (0%) 10.872 2.412E-04
STABLE ISOTOPE Bioterm 19 (6%) 10 (1%) 5.902 2.436E-04
PSORIATICS Bioterm 2 (0%) 64 (7%) 10.301 2.449E-04
MOTOR Bioterm 35 (12%) 36 (4%) 3.02 2.692E-04
STEP Bioterm 146 (51%) 315 (35%) 1.44 3.775E-04
HISTONE Bioterm 56 (19%) 80 (9%) 2.174 3.878E-04
ANEUPLOIDY Bioterm 17 (6%) 8 (0%) 6.601 4.021E-04
COORDINATION Bioaction 80 (28%) 137 (15%) 1.814 4.581E-04
PURIFIED Bioaction 154 (54%) 340 (38%) 1.407 4.765E-04
PROTEOME Bioterm 106 (37%) 205 (23%) 1.606 5.090E-04
NUCLEUS Bioaction 116 (41%) 232 (26%) 1.553 5.112E-04
MINICHROMOSOME Bioterm 10 (3%) 1 (0%) 31.064 5.885E-04
DEPLETION Bioaction 79 (28%) 135 (15%) 1.818 6.009E-04
NONPHOSPHORYLATABLE Bioterm 15 (5%) 6 (0%) 7.766 6.104E-04
EMPIRICAL Bioterm 35 (12%) 37 (4%) 2.938 6.143E-04
TOPOISOMERASE Bioterm 18 (6%) 10 (1%) 5.591 6.898E-04
ASSEMBLIES Bioterm 89 (31%) 162 (18%) 1.707 7.018E-04
DNA REPLICATION Bioterm 27 (9%) 24 (2%) 3.495 7.144E-04
SCHIZOSACCHAROMYCES Bioterm 14 (4%) 5 (0%) 8.698 7.164E-04
SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLE Bioterm 13 (4%) 4 (0%) 10.096 8.007E-04
ARREST Bioaction 61 (21%) 94 (10%) 2.016 8.323E-04
CROSS-VALIDATION Bioaction 32 (11%) 33 (3%) 3.012 8.876E-04
EUKARYOTIC CELL Bioterm 32 (11%) 33 (3%) 3.012 8.876E-04
UPPER Bioterm 5 (1%) 78 (8%) 5.022 9.008E-04
LEAVES Bioterm 17 (6%) 9 (1%) 5.868 9.071E-04
KINETOCHORE Bioterm 17 (6%) 9 (1%) 5.868 9.071E-04
TOPOLOGIES Bioterm 100 (35%) 191 (21%) 1.626 9.248E-04
HAIR FOLLICLE Bioterm 3 (1%) 67 (7%) 7.189 9.454E-04
ELONGATION FACTOR Bioterm 62 (21%) 97 (11%) 1.986 1.034E-03
OLIGORIBONUCLEOTIDES Chemical 53 (18%) 76 (8%) 2.166 1.052E-03
INTEGRATED Bioaction 128 (45%) 270 (30%) 1.473 1.094E-03
PHOSPHOPEPTIDES Chemical 31 (10%) 31 (3%) 3.106 1.095E-03
PERCENT Bioterm 60 (21%) 93 (10%) 2.004 1.190E-03
CDH1 Gene 8 (2%) 0 (0%) - 1.204E-03
RP-A Gene 8 (2%) 0 (0%) - 1.204E-03
LYSATE Bioterm 71 (25%) 120 (13%) 1.838 1.371E-03
SUPRABASAL Bioterm 3 (1%) 64 (7%) 6.868 1.428E-03
POLYPEPTIDE CHAIN ELONGATION FACTOR 1 ALPHA Gene 52 (18%) 76 (8%) 2.125 1.696E-03
MICROTUBULE Bioterm 48 (17%) 67 (7%) 2.225 1.777E-03
PROTEIN COMPLEX Gene 21 (7%) 16 (1%) 4.077 1.884E-03
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY Bioterm 30 (10%) 31 (3%) 3.006 2.001E-03
MULTISUBUNIT Bioterm 19 (6%) 13 (1%) 4.54 2.010E-03
INITIATION FACTOR Bioterm 19 (6%) 13 (1%) 4.54 2.010E-03
UNPRECEDENTED Bioterm 27 (9%) 26 (2%) 3.226 2.231E-03
CYCLOSOME Bioterm 9 (3%) 1 (0%) 27.957 2.256E-03
RDNA Bioterm 9 (3%) 1 (0%) 27.957 2.256E-03
MULTIPOLAR Bioterm 9 (3%) 1 (0%) 27.957 2.256E-03
NEURITE Bioterm 20 (7%) 15 (1%) 4.142 2.643E-03
MOTIF Bioterm 157 (55%) 360 (41%) 1.355 2.644E-03
CLADE Bioterm 10 (3%) 2 (0%) 15.532 2.772E-03
PSORIASIS Disease 4 (1%) 68 (7%) 5.473 2.782E-03
FORK Bioaction 11 (3%) 3 (0%) 11.39 2.830E-03
EGF Gene 64 (22%) 106 (12%) 1.876 2.904E-03
BIOGENESIS Bioterm 27 (9%) 27 (3%) 3.106 3.074E-03
5'-PHOSPHATES Chemical 49 (17%) 72 (8%) 2.114 3.127E-03
PYROPHOSPHATASE Bioterm 49 (17%) 72 (8%) 2.114 3.127E-03
AUTISM Disease 23 (8%) 20 (2%) 3.572 3.251E-03
JUNCTIONAL Bioterm 1 (0%) 46 (5%) 14.808 3.986E-03
STRATUM CORNEUM Bioterm 1 (0%) 47 (5%) 15.13 4.214E-03
HISTONES Gene 14 (4%) 7 (0%) 6.213 4.381E-03
REPLICATION Bioaction 73 (25%) 130 (14%) 1.744 4.762E-03
OLIGORIBONUCLEOTIDE Chemical 49 (17%) 73 (8%) 2.085 5.036E-03
MAD2 Gene 7 (2%) 0 (0%) - 5.041E-03
CDT1 Gene 7 (2%) 0 (0%) - 5.041E-03
UNALIGNED Bioterm 7 (2%) 0 (0%) - 5.041E-03
HSPS Gene 7 (2%) 0 (0%) - 5.041E-03
MONOPOLAR Bioterm 7 (2%) 0 (0%) - 5.041E-03
MACHINE Bioterm 54 (19%) 84 (9%) 1.997 5.125E-03
SUBSTRATE Bioterm 124 (43%) 268 (30%) 1.437 5.149E-03
NATIONALS Bioterm 272 (96%) 779 (88%) 1.085 5.271E-03
IN-GEL Bioterm 13 (4%) 6 (0%) 6.73 5.590E-03
CYTOGENETIC Bioterm 31 (10%) 36 (4%) 2.675 5.678E-03
CORNIFIED Bioaction 0 (0%) 41 (4%) - 5.814E-03
CALCIUM Chemical 29 (10%) 181 (20%) 2.009 5.998E-03
MATCHED Bioaction 120 (42%) 258 (29%) 1.445 6.094E-03
LININGS Bioterm 1 (0%) 45 (5%) 14.486 6.604E-03
REPAIR Bioaction 50 (17%) 77 (8%) 2.017 7.164E-03
SUPPLEMENTAL Bioterm 27 (9%) 29 (3%) 2.892 8.417E-03
SUPERFAMILIES Bioterm 37 (13%) 209 (23%) 1.818 8.455E-03
UNATTACHED Bioterm 8 (2%) 1 (0%) 24.851 8.544E-03
TRANSMISSION Bioaction 77 (27%) 144 (16%) 1.661 8.928E-03
ATPASE Gene 18 (6%) 14 (1%) 3.994 9.212E-03
CYCLIN B Gene 10 (3%) 3 (0%) 10.355 9.431E-03
NUCLEAR PROTEIN Gene 10 (3%) 3 (0%) 10.355 9.431E-03
HEAT-SHOCK Bioterm 9 (3%) 2 (0%) 13.979 9.760E-03
POLO-LIKE KINASE 1 Gene 9 (3%) 2 (0%) 13.979 9.760E-03
CAMPTOTHECIN Drug 9 (3%) 2 (0%) 13.979 9.760E-03
MISALIGNMENT Bioaction 9 (3%) 2 (0%) 13.979 9.760E-03
LIGATED Bioaction 60 (21%) 102 (11%) 1.827 1.102E-02
NONREDUNDANT Bioterm 272 (96%) 782 (89%) 1.08 1.115E-02
SCALE Bioaction 92 (32%) 184 (21%) 1.553 1.139E-02
REMOVED Bioaction 88 (31%) 173 (19%) 1.58 1.150E-02
TOBACCO Bioterm 52 (18%) 84 (9%) 1.923 1.227E-02
NICOTIANA TABACUM Organism 52 (18%) 84 (9%) 1.923 1.227E-02
MAPPINGS Bioterm 167 (59%) 403 (46%) 1.287 1.292E-02
NUCLEAR ANTIGEN Bioterm 17 (6%) 13 (1%) 4.062 1.294E-02
PCNA Gene 17 (6%) 13 (1%) 4.062 1.294E-02
UNLIKE Bioterm 99 (35%) 204 (23%) 1.508 1.356E-02
CYCLIN-DEPENDENT KINASES Gene 15 (5%) 10 (1%) 4.66 1.373E-02
941 PSEUDOGENES Gene 15 (5%) 10 (1%) 4.66 1.373E-02
CYSTIC FIBROSIS GENE Gene 15 (5%) 10 (1%) 4.66 1.373E-02
SYNTHESIS Bioaction 147 (52%) 343 (39%) 1.331 1.448E-02
PSMS Chemical 23 (8%) 23 (2%) 3.106 1.466E-02
STARVATION Bioaction 23 (8%) 23 (2%) 3.106 1.466E-02
SYSTEMATICS Bioterm 119 (42%) 261 (29%) 1.416 1.538E-02
STARVATION Symptom 21 (7%) 20 (2%) 3.262 1.551E-02
SUBUNIT Bioterm 102 (36%) 213 (24%) 1.488 1.631E-02
INVOLUCRIN Gene 1 (0%) 41 (4%) 13.199 1.654E-02
NETWORK Bioterm 274 (97%) 795 (90%) 1.071 1.812E-02
REGULATORY Bioterm 134 (47%) 306 (34%) 1.36 1.915E-02
KINETICS Bioterm 94 (33%) 193 (22%) 1.513 1.971E-02
QUIESCENT Bioterm 23 (8%) 24 (2%) 2.977 1.976E-02
SUBCELLULAR Bioterm 118 (41%) 260 (29%) 1.41 2.022E-02
EPIDERMAL CELL Bioterm 3 (1%) 54 (6%) 5.795 2.050E-02
INTERMEDIATE FILAMENT Bioterm 3 (1%) 54 (6%) 5.795 2.050E-02
SURPRISINGLY Bioterm 81 (28%) 159 (18%) 1.582 2.082E-02
DNA-BINDING PROTEIN Gene 11 (3%) 5 (0%) 6.834 2.090E-02
ATAXIA TELANGIECTASIA Disease 11 (3%) 5 (0%) 6.834 2.090E-02
MAD1 Gene 6 (2%) 0 (0%) - 2.104E-02
CDK2/ Gene 6 (2%) 0 (0%) - 2.104E-02
CHK1 PROTEIN KINASE Gene 6 (2%) 0 (0%) - 2.104E-02
E2F TRANSCRIPTION FACTOR Chemical 6 (2%) 0 (0%) - 2.104E-02
SINGLE MAGE-A ANTIGEN Gene 6 (2%) 0 (0%) - 2.104E-02
MAGE-A ANTIGENS Gene 6 (2%) 0 (0%) - 2.104E-02
CDK2 KINASE Gene 6 (2%) 0 (0%) - 2.104E-02
RIBONUCLEOTIDE Chemical 6 (2%) 0 (0%) - 2.104E-02
HIGH-SENSITIVE REVERSE TRANSCRIPTION-NESTED POLYMERASE CHAIN Gene 6 (2%) 0 (0%) - 2.104E-02
E2F4 Gene 6 (2%) 0 (0%) - 2.104E-02
APC/ C Gene 6 (2%) 0 (0%) - 2.104E-02
REPLICATION PROTEIN A Gene 6 (2%) 0 (0%) - 2.104E-02
RAD17 Gene 6 (2%) 0 (0%) - 2.104E-02
REBINDING Bioaction 6 (2%) 0 (0%) - 2.104E-02
PRE-RRNA Chemical 6 (2%) 0 (0%) - 2.104E-02
POLYPLOID Bioterm 6 (2%) 0 (0%) - 2.104E-02
H2B Gene 6 (2%) 0 (0%) - 2.104E-02
HUMAN GENE MAGE-1 Chemical 6 (2%) 0 (0%) - 2.104E-02
MAGE Gene 6 (2%) 0 (0%) - 2.104E-02
12 MAGE Gene 6 (2%) 0 (0%) - 2.104E-02
COHESIN Bioterm 6 (2%) 0 (0%) - 2.104E-02
MAGE-A Gene 6 (2%) 0 (0%) - 2.104E-02
MELANOMA ANTIGEN GENE Chemical 6 (2%) 0 (0%) - 2.104E-02
CDC20 Gene 6 (2%) 0 (0%) - 2.104E-02
ATM KINASES Gene 6 (2%) 0 (0%) - 2.104E-02
PERMIT Bioaction 61 (21%) 108 (12%) 1.755 2.220E-02
SURFACE Bioaction 71 (25%) 325 (37%) 1.474 2.377E-02
CONNECTION Bioaction 116 (41%) 255 (29%) 1.413 2.471E-02
VIRAL PROTEIN Bioterm 18 (6%) 15 (1%) 3.728 2.488E-02
INDEPENDENT Bioterm 182 (64%) 456 (52%) 1.24 2.722E-02
DISPENSABLE Bioterm 24 (8%) 26 (2%) 2.867 2.830E-02
CO-IMMUNOPRECIPITATION Bioaction 95 (33%) 197 (22%) 1.498 2.866E-02
IMPRINTING Bioaction 22 (7%) 23 (2%) 2.971 2.895E-02
ASSEMBLED Bioaction 63 (22%) 114 (13%) 1.717 2.904E-02
PROTEASOME Bioterm 44 (15%) 68 (7%) 2.01 2.952E-02
END Bioaction 142 (50%) 332 (37%) 1.329 2.997E-02
POL Chemical 9 (3%) 3 (0%) 9.319 3.073E-02
STEM-LOOP Bioterm 9 (3%) 3 (0%) 9.319 3.073E-02
NOVEL PROTEIN-PROTEIN Gene 35 (12%) 49 (5%) 2.219 3.158E-02
TOPOISOMERASE I Gene 7 (2%) 1 (0%) 21.745 3.190E-02
BUBR1 Gene 7 (2%) 1 (0%) 21.745 3.190E-02
XERODERMA PIGMENTOSUM Disease 7 (2%) 1 (0%) 21.745 3.190E-02
CLASPIN Gene 7 (2%) 1 (0%) 21.745 3.190E-02
SPECTRAL Bioterm 27 (9%) 33 (3%) 2.542 3.287E-02
MUS SP Organism 73 (25%) 329 (37%) 1.451 3.337E-02
IMMUNODEPLETED Bioaction 8 (2%) 2 (0%) 12.426 3.370E-02
DOUBLE-STRANDED DNA Bioterm 12 (4%) 7 (0%) 5.325 3.475E-02
FRACTION Bioaction 117 (41%) 260 (29%) 1.398 3.485E-02
REMAIN Bioaction 163 (57%) 398 (45%) 1.272 3.770E-02
BRONCHIAL Bioterm 8 (2%) 78 (8%) 3.139 3.827E-02
MECHANISM Bioterm 212 (75%) 558 (63%) 1.18 3.881E-02
CALCIUM-DEPENDENT Bioterm 2 (0%) 45 (5%) 7.243 3.901E-02
DEGRADATION Bioaction 95 (33%) 201 (22%) 1.468 4.306E-02
BONE MARROW CELL Bioterm 15 (5%) 12 (1%) 3.883 4.466E-02
HEALTH Bioterm 271 (96%) 784 (89%) 1.074 4.478E-02
STIMULI Bioterm 70 (24%) 134 (15%) 1.623 4.517E-02
NUCLEAR PORE Bioterm 11 (3%) 6 (0%) 5.695 4.646E-02
CLASSIFICATION Bioaction 87 (30%) 179 (20%) 1.51 4.690E-02
KINASES Gene 32 (11%) 44 (5%) 2.259 4.748E-02
METAPHASE Bioterm 28 (9%) 36 (4%) 2.416 4.892E-02